PVI
IART icon

Pura Vida Investments’s Integra LifeSciences IART Stock Holding History

Pura Vida Investments’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25,000
Closed -$1.4M – 109
2019
Q2 		$1.4M Buy
+25,000
New +$1.29M 0.21% 89

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pura Vida Investments's IART Position: Q3 2019 in Review

Pura Vida Investments sold out of Integra LifeSciences (IART) in Q3 2019, closing a stake of 25,000 shares — an estimated $1.4M sold.

Pura Vida Investments first reported a position in IART in Q2 2019 and held it in 1 quarter. The position peaked at $1.4M in Q2 2019. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

  • Pura Vida Investments reported no remaining Integra LifeSciences position as of Q3 2019 after selling out during the quarter.
  • Pura Vida Investments sold 25,000 Integra LifeSciences shares in Q3 2019, an estimated $1.4M.
  • Pura Vida Investments first reported a position in Integra LifeSciences in Q2 2019 and held it in 1 quarter.
  • Pura Vida Investments's Integra LifeSciences position peaked at $1.4M in Q2 2019.
  • 280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Pura Vida Investments's 13F filing for Q3 2019, filed 14 Nov 2019.